– Arzneimittelinformation Swissmedic (
www.swissmedicinfo.ch)
– Micromedex® 2.0, (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at:
http://www.micromedexsolutions.com (Zugriff 01.Januar 2017).
– Coutre S. Clinical presentation and diagnosis of heparin-induced thrombocytopenia. In: UpToDate, Leung LLK (Ed), UpToDate, Waltham, MA. (Zugriff 20. Februar 2017).
– Salter BS, Weiner MM, Trinh MA, Heller J, Evans AS, Adams DH, Fischer GW. Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review. J Am Coll Cardiol. 2016;67:2519–32.
– Warkentin TE. An overview of the heparin-induced thrombocytopenia syndrome. Semin Thromb Hemost. 2004; 30:273-83.
– Davoren A, Aster RH. Heparin-induced thrombocytopenia and thrombosis. Am J Hematol. 2006;81:36–44.
– Greinacher A. CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia. N Engl J Med. 2015;373:252–61.
– Medsafe – New Zealand Medicines and Medical Devices Safety Authority. Don’t get HIT: Heparin-induced Thrombocytopenia. Prescriber Update. 2016;37:59–60.